{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T05:29:46Z","timestamp":1793683786605,"version":"4.5.1"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T00:00:00Z","timestamp":1681430400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.ejmech.2023.115373","type":"journal-article","created":{"date-parts":[[2023,4,14]],"date-time":"2023-04-14T11:05:25Z","timestamp":1681470325000},"page":"115373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Antibacterial and antibiofilm activity of permanently ionized quaternary ammonium fluoroquinolones"],"prefix":"10.1016","volume":"254","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7524-9909","authenticated-orcid":false,"given":"Joanna","family":"Fedorowicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina D.","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Morawska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzesimir","family":"Ciura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shella","family":"Gilbert-Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"M\u00e4kkyl\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina","family":"Ilina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsi","family":"Savijoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adyary","family":"Fallarero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00e4ivi","family":"Tammela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaros\u0142aw","family":"S\u0105czewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115373_bib1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Murray","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.ejmech.2023.115373_bib2","article-title":"Antibiotic resistance: turning evolutionary principles into clinical reality","volume":"44","author":"Andersson","year":"2021","journal-title":"FEMS Microbiol. Rev."},{"key":"10.1016\/j.ejmech.2023.115373_bib3","first-page":"416","article-title":"The negative impact of antibiotic resistance","volume":"22","author":"Friedman","year":"2016","journal-title":"MCI"},{"key":"10.1016\/j.ejmech.2023.115373_bib4","doi-asserted-by":"crossref","first-page":"735","DOI":"10.2147\/IDR.S345574","article-title":"Clinical perspective of antimicrobial resistance in bacteria","volume":"15","author":"Zhu","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.ejmech.2023.115373_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0189621","article-title":"Clinical and economic impact of antibiotic resistance in developing countries: a systematic review and meta-analysis","volume":"12","author":"Founou","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2023.115373_bib6","first-page":"e1403","article-title":"A review on antibiotic resistance: alarm bells are ringing","volume":"9","author":"Zaman","year":"2017","journal-title":"Cureus"},{"key":"10.1016\/j.ejmech.2023.115373_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114888","article-title":"1,2,3-Triazole-containing hybrids with potential antibacterial activity against ESKAPE pathogens","volume":"244","author":"Deng","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113200","article-title":"New dual ATP-competitive inhibitors of bacterial DNA gyrase and topoisomerase IV active against ESKAPE pathogens","volume":"213","author":"Durcik","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127799","article-title":"Recent advances in antibacterial agents","volume":"35","author":"Kong","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115373_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.amjmed.2005.05.009","article-title":"Appropriate antibiotic treatment of genitourinary infections in hospitalized patients","volume":"118","author":"Liu","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejmech.2023.115373_bib11","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ejmech.2023.115373_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113741","article-title":"The antibacterial activity of fluoroquinolone derivatives: an update (2018-2021)","volume":"224","author":"Jia","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.116674","article-title":"Recent insight into the biological activities and SAR of quinolone derivatives as multifunctional scaffold","volume":"59","author":"Sharma","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/jac\/dkg212","article-title":"Development of the quinolones","volume":"51","author":"Andersson","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2023.115373_bib15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejmech.2012.07.010","article-title":"Synthesis and in vitro antibacterial activity of gemifloxacin derivatives containing a substituted benzyloxime moiety","volume":"55","author":"Feng","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128432","article-title":"Design and synthesis of an oral prodrug alalevonadifloxacin for the treatment of MRSA infection","volume":"54","author":"Bhawsar","year":"2021","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115373_bib17","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jac\/45.5.583","article-title":"Intracellular targets of moxifloxacin: a comparison with other fluoroquinolones","volume":"45","author":"Pestova","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2023.115373_bib18","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1128\/AAC.44.3.798-801.2000","article-title":"Convenient assay for estimating the possible involvement of efflux of fluoroquinolones by streptococcus pneumoniae and staphylococcus aureus: evidence for diminished moxifloxacin, sparfloxacin, and trovafloxacin efflux","volume":"44","author":"Beyer","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115373_bib19","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1128\/AAC.44.2.304-310.2000","article-title":"Antipneumococcal activities of gemifloxacin compared to those of nine other agents","volume":"44","author":"Davies","year":"2000","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115373_bib20","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejps.2016.07.016","article-title":"Solubility, lipophilicity and membrane permeability of some fluoroquinolone antimicrobials","volume":"93","author":"Blokhina","year":"2016","journal-title":"Eur. J. Pharmaceut. Sci."},{"key":"10.1016\/j.ejmech.2023.115373_bib21","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1016\/j.bmc.2009.04.027","article-title":"Design, synthesis, antibacterial activity and physicochemical parameters of novel N-4-piperazinyl derivatives of norfloxacin","volume":"17","author":"Abuo-Rahma","year":"2009","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib22","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/AAC.32.4.438","article-title":"Routes of quinolone permeation in Escherichia coli","volume":"32","author":"Chapman","year":"1988","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115373_bib23","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/jac\/34.4.465","article-title":"Interaction of divalent cations, quinolones and bacteria","volume":"34","author":"Marshall","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2023.115373_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.jpba.2004.10.022","article-title":"Protonation equilibrium and lipophilicity of moxifloxacin","volume":"37","author":"Langlois","year":"2005","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejmech.2023.115373_bib25","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1128\/AAC.38.6.1345","article-title":"Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the staphylococcus aureus chromosome","volume":"38","author":"Ng","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115373_bib26","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/AAC.37.7.1393","article-title":"Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples","volume":"37","author":"Nikaido","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115373_bib27","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s00706-018-2215-x","article-title":"Modifications of quinolones and fluoroquinolones: hybrid compounds and dual-action molecules","volume":"149","author":"Fedorowicz","year":"2018","journal-title":"Monatsh. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128885","article-title":"Pyrimidine-conjugated fluoroquinolones as new potential broad-spectrum antibacterial agents","volume":"73","author":"Tan","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115373_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128484","article-title":"Synthesis and evaluation of dual-action kanglemycin-fluoroquinolone hybrid antibiotics","volume":"57","author":"Peek","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115373_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.114021","article-title":"Design and synthesis of ciprofloxacin-sulfonamide hybrids to manipulate ciprofloxacin pharmacological qualities: potency and side effects","volume":"228","author":"Ibrahim","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2022.117004","article-title":"New potent ciprofloxacin-uracil conjugates as DNA gyrase and topoisomerase IV inhibitors against methicillin-resistant Staphylococcus aureus","volume":"73","author":"Samir","year":"2022","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib32","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/cmdc.201900607","article-title":"Dual Escherichia coli DNA gyrase A and B inhibitors with antibacterial activity","volume":"15","author":"Fois","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2023.115373_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114765","article-title":"Antibacterial quaternary ammonium agents: chemical diversity and biological mechanism","volume":"243","author":"Dan","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2020.108774","article-title":"Synthesis of diosgenyl quaternary ammonium derivatives and their antitumor activity","volume":"166","author":"Xia","year":"2021","journal-title":"Steroids"},{"key":"10.1016\/j.ejmech.2023.115373_bib35","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1080\/14756366.2021.2015344","article-title":"2-arylquinolines as novel anticancer agents with dual EGFR\/FAK kinase inhibitory activity: synthesis, biological evaluation, and molecular modelling insights","volume":"37","author":"Elbadawi","year":"2022","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib36","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/cmdc.201800546","article-title":"Inhibition of human topoisomerase II by N,N,N-trimethylethanammonium iodide alkylcarbazole derivatives","volume":"13","author":"Saturnino","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2023.115373_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.128450","article-title":"Lipophilic quinolone derivatives: synthesis and in vitro antibacterial evaluation","volume":"55","author":"Sadowski","year":"2022","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115373_bib38","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.ejmech.2019.06.071","article-title":"Synthesis and biological evaluation of hybrid quinolone-based quaternary ammonium antibacterial agents","volume":"179","author":"Fedorowicz","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib39","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.3390\/ijms20215288","article-title":"Lipophilicity determination of quaternary (Fluoro)Quinolones by chromatographic and theoretical approaches","volume":"20","author":"Ciura","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2023.115373_bib40","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.3390\/pr8091148","article-title":"Affinity of fluoroquinolone\u2013safirinium dye hybrids to phospholipids estimated by IAM-HPLC","volume":"8","author":"Ciura","year":"2020","journal-title":"Processes"},{"key":"10.1016\/j.ejmech.2023.115373_bib41","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/157340612800786633","article-title":"SAR analysis of new dual targeting fluoroquinolones. implications of the benzenesulfonyl group","volume":"8","author":"Nieto","year":"2012","journal-title":"Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib42","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1365-2125.2011.03991.x","article-title":"Neurotoxic effects associated with antibiotic use: management considerations","volume":"72","author":"F Grill","year":"2011","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115373_bib43","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11094-007-0018-1","article-title":"Quantitative structure-pharmacokinetic\/pharmacodynamic relationship for fluoroquinolones","volume":"41","author":"Li","year":"2007","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejmech.2023.115373_bib44","first-page":"1869","article-title":"Developing ciprofloxacin analogues against plant DNA gyrase: a novel herbicide mode of action","volume":"54","author":"Wallace","year":"2018","journal-title":"Chem"},{"key":"10.1016\/j.ejmech.2023.115373_bib45","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1021\/jm00186a014","article-title":"Structure-activity relationships of antibacterial 6, 7-and 7, 8-disubstituted 1-alkyl-1, 4-dihydro-4-oxoquinoline-3-carboxylic acids","volume":"23","author":"Koga","year":"1980","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib46","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1021\/ci200387c","article-title":"Revisiting the general solubility equation: in silico prediction of aqueous solubility incorporating the effect of topographical polar surface area","volume":"52","author":"Ali","year":"2012","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2023.115373_bib47","doi-asserted-by":"crossref","first-page":"428","DOI":"10.3389\/fphar.2020.00428","article-title":"Quinolones-induced musculoskeletal, neurological, and psychiatric ADRs: a pharmacovigilance study based on data from the Italian spontaneous reporting system","volume":"11","author":"Scavone","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.ejmech.2023.115373_bib48","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.1021\/jm000292e","article-title":"Prediction of drug absorption using multivariate statistics","volume":"43","author":"Egan","year":"2000","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib49","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1021\/cc9800071","article-title":"A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases","volume":"1","author":"Ghose","year":"1999","journal-title":"J. Comb. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib50","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1021\/jm020017n","article-title":"Molecular properties that influence the oral bioavailability of drug candidates","volume":"45","author":"Veber","year":"2002","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib51","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1021\/jm015507e","article-title":"Simple selection criteria for drug-like chemical matter","volume":"44","author":"Muegge","year":"2001","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib52","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.jpba.2016.04.009","article-title":"Lipophilicity and biomimetic properties measured by HPLC to support drug discovery","volume":"130","author":"Valk\u00f3","year":"2016","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.ejmech.2023.115373_bib53","doi-asserted-by":"crossref","first-page":"28","DOI":"10.15698\/mic2021.02.741","article-title":"Biofilms by bacterial human pathogens: clinical relevance \u2013 development, composition and regulation - therapeutical strategies","volume":"8","author":"Schulze","year":"2021","journal-title":"Microb. Cell"},{"key":"10.1016\/j.ejmech.2023.115373_bib54","article-title":"A platform of anti-biofilm assays suited to the exploration of natural compound libraries","volume":"2016","author":"Skogman","year":"2016","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.ejmech.2023.115373_bib55","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.mimet.2009.04.014","article-title":"Pros and cons of using resazurin staining for quantification of viable staphylococcus aureus biofilms in a screening assay","volume":"78","author":"Sandberg","year":"2009","journal-title":"J. Microbiol. Methods"},{"key":"10.1016\/j.ejmech.2023.115373_bib56","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ja.2012.49","article-title":"Combining biofilm matrix measurements with biomass and viability assays in susceptibility assessments of antimicrobials against staphylococcus aureus biofilms","volume":"65","author":"Skogman","year":"2012","journal-title":"J. Antibiot."},{"key":"10.1016\/j.ejmech.2023.115373_bib58","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.2174\/092986707781368414","article-title":"Discovery and development of ATPase inhibitors of DNA gyrase as antibacterial agents","volume":"14","author":"Oblak","year":"2007","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib59","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/nsmb.1892","article-title":"Structural basis of quinolone inhibition of type IIA topoisomerases and target-mediated resistance","volume":"17","author":"Wohlkonig","year":"2010","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.115373_bib60","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/S1369-5274(99)00008-9","article-title":"Mechanism of fluoroquinolone action","volume":"2","author":"Drlica","year":"1999","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2023.115373_bib61","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.ejmech.2023.115373_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10048","article-title":"Structural basis of DNA gyrase inhibition by antibacterial QPT-1, anticancer drug etoposide and moxifloxacin","volume":"6","author":"Chan","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ejmech.2023.115373_bib64","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1107\/S2059798316001212","article-title":"Structure of a quinolone-stabilized cleavage complex of topoisomerase IV from Klebsiella pneumoniae and comparison with a related Streptococcus pneumoniae complex","volume":"72","author":"Veselkov","year":"2016","journal-title":"Acta. Crystallogr. D. Struct. Biol."},{"key":"10.1016\/j.ejmech.2023.115373_bib65","unstructured":"Release 4.1.2.2, OpenEye Scientific Software, Inc., Santa Fe, NM, USA; www.eyesopen.com."},{"key":"10.1016\/j.ejmech.2023.115373_bib66","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1128\/AAC.38.6.1345","article-title":"Quinolone resistance mediated by norA: physiologic characterization and relationship to flqB, a quinolone resistance locus on the Staphylococcus aureus chromosome","volume":"38","author":"Ng","year":"1994","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115373_bib67","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1128\/AAC.37.7.1393","article-title":"Penetration of lipophilic agents with multiple protonation sites into bacterial cells: tetracyclines and fluoroquinolones as examples","volume":"37","author":"Nikaido","year":"1993","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115373_bib68","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1128\/AAC.32.4.438","article-title":"Routes of quinolone permeation in Escherichia coli, Antimicrob","volume":"32","author":"Chapman","year":"1988","journal-title":"Agents Chemother."},{"key":"10.1016\/j.ejmech.2023.115373_bib69","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/jac\/34.4.465","article-title":"Interaction of divalent cations, quinolones and bacteria","volume":"34","author":"Marshall","year":"1994","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2023.115373_bib70","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0005-2736(02)00577-1","article-title":"The structure of bacterial outer membrane proteins","volume":"1565","author":"Schulz","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ejmech.2023.115373_bib71","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1128\/MMBR.67.4.593-656.2003","article-title":"Molecular basis of bacterial outer membrane permeability revisited","volume":"67","author":"Nikaido","year":"2003","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.ejmech.2023.115373_bib72","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nrmicro1994","article-title":"The porin and the permeating antibiotic: a selective diffusion barrier in Gram-negative bacteria","volume":"6","author":"Pages","year":"2008","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.ejmech.2023.115373_bib73","doi-asserted-by":"crossref","first-page":"11531","DOI":"10.1002\/chem.201302085","article-title":"The tandem Mannich \u2013 electrophilic amination reaction: a versatile platform for fluorescent probing and labeling","volume":"19","author":"S\u0105czewski","year":"2013","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.ejmech.2023.115373_bib74","doi-asserted-by":"crossref","first-page":"8975","DOI":"10.1016\/j.tet.2015.09.050","article-title":"Experimental and theoretical studies on the tautomerism and reactivity of isoxazolo[3,4-b]quinolin-3(1H)-ones","volume":"71","author":"S\u0105czewski","year":"2015","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2023.115373_bib75","series-title":"Agilent Technologies: CrysAlisPRO Software System","year":"2014"},{"key":"10.1016\/j.ejmech.2023.115373_bib76","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053273314026370","article-title":"SHELXT \u2013 integrated space-group and crystal-structure determination","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. A. Found. Crystallogr."},{"key":"10.1016\/j.ejmech.2023.115373_bib77","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1107\/S2053229614024218","article-title":"Crystal structure refinement with SHELXL","volume":"71","author":"Sheldrick","year":"2015","journal-title":"Acta Crystallogr. C. Struct. Chem."},{"key":"10.1016\/j.ejmech.2023.115373_bib78","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1107\/S0021889899006020","article-title":"WinGX suite for small-molecule single-crystal crystallography","volume":"32","author":"Faruggia","year":"1999","journal-title":"J. Appl. Crystallogr."},{"key":"10.1016\/j.ejmech.2023.115373_bib79","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1107\/S0108768102003890","article-title":"The Cambridge Structural Database: a quarter of a million crystal structures and rising","volume":"58","author":"Allen","year":"2002","journal-title":"Acta Crystallogr. B. Struct. Sci. Cryst. Eng. Mater."},{"key":"10.1016\/j.ejmech.2023.115373_bib80","series-title":"Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically; Approved Standard","year":"2015"},{"key":"10.1016\/j.ejmech.2023.115373_bib85","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/bip.10207","article-title":"Gaussian docking functions","volume":"68","author":"McGann","year":"2003","journal-title":"Biopolymers"},{"key":"10.1016\/j.ejmech.2023.115373_bib86","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1021\/ci700052x","article-title":"Comparison of topological, shape, and docking methods in virtual screening","volume":"47","author":"McGaughey","year":"2007","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2023.115373_bib87","unstructured":"Release 4.2.0.1, OpenEye Scientific Software, Inc., Santa Fe, NM, USA; www.eyesopen.com."},{"key":"10.1016\/j.ejmech.2023.115373_bib88","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1021\/ci100031x","article-title":"Conformer generation with OMEGA: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database","volume":"50","author":"Hawkins","year":"2010","journal-title":"J. Chem. Inf. Model."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423003392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423003392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:52:19Z","timestamp":1759330339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423003392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":82,"alternative-id":["S0223523423003392"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115373","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antibacterial and antibiofilm activity of permanently ionized quaternary ammonium fluoroquinolones","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115373","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115373"}}